|
WO2008041116A2
|
|
Formulations of active principles incorporated in slns suitable for transdermal administration
|
|
US2009306032A1
|
|
Use of solid lipid nanoparticles Comprising Cholesteryl Propionate and/or Cholesteryl Butyrate
|
|
EP1761251A1
|
|
Lipid nanoparticles as vehicles for nucleic acids, process for their preparation and use
|
|
CA2504199A1
|
|
Pharmaceutical compositions suitable for the treatment of ophthalmic diseases
|
|
AU1654200A
|
|
Solid lipidic nanospheres suitable to a fast internalization into cells
|
|
WO9927918A1
|
|
Microparticles for drug delivery across mucosa and the blood-brain barrier
|
|
CA2294172A1
|
|
Pharmaceutical composition in form of solid lipidic microparticles suitable to parenteral administration
|
|
EP0526666A1
|
|
Solid lipid microspheres having a narrow size distribution and method for producing them
|
